Aratana Therapeutics

United States
Centerville, Georgia, United States

Company profile

Aratana Therapeutics company profile

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.

Business identity

Phone number
913-951-2130
Operating status
Closed
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2010-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
8
Total equity funding
$138.5M
Last funding
Post IPO Equity / $11.7M / 2018-03-15
Last equity funding
Post IPO Equity / $11.7M
Investors
14
Lead investors
3
Founders
1
Articles
30
Closed on
2019-04-26
Exited on
2013-06-27

Founders and investors

Founders

Steven Peter

Lead investors

Avalon VenturesKauffman FoundationMPM Capital

Investors

Avalon VenturesKauffman FoundationMPM CapitalOxford Finance LLCSandbox Industries